IRIS Accounts Production v25.1.3.33 07900359 director 1.10.23 30.9.24 30.9.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh079003592023-09-30079003592024-09-30079003592023-10-012024-09-30079003592022-09-30079003592022-10-012023-09-30079003592023-09-3007900359ns15:EnglandWales2023-10-012024-09-3007900359ns14:PoundSterling2023-10-012024-09-3007900359ns10:Director12023-10-012024-09-3007900359ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3007900359ns10:SmallEntities2023-10-012024-09-3007900359ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3007900359ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3007900359ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3007900359ns10:FullAccounts2023-10-012024-09-3007900359ns5:CurrentFinancialInstruments2024-09-3007900359ns5:CurrentFinancialInstruments2023-09-3007900359ns5:ShareCapital2024-09-3007900359ns5:ShareCapital2023-09-3007900359ns5:RetainedEarningsAccumulatedLosses2024-09-3007900359ns5:RetainedEarningsAccumulatedLosses2023-09-3007900359ns10:RegisteredOffice2023-10-012024-09-300790035912023-10-012024-09-3007900359ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3007900359ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-300790035912023-10-012024-09-30
REGISTERED NUMBER: 07900359 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024

FOR

MEDICOTHERAPY SERVICES LIMITED

MEDICOTHERAPY SERVICES LIMITED (REGISTERED NUMBER: 07900359)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024










Page

Statement of Financial Position 1

Notes to the Financial Statements 2 to 3


MEDICOTHERAPY SERVICES LIMITED (REGISTERED NUMBER: 07900359)

STATEMENT OF FINANCIAL POSITION
30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £   
CURRENT ASSETS
Debtors 4 82,195 83,142
Cash at bank 799 947
82,994 84,089
CREDITORS
Amounts falling due within one year 5 (4,206 ) (4,461 )
NET CURRENT ASSETS 78,788 79,628
TOTAL ASSETS LESS CURRENT
LIABILITIES

78,788

79,628

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 78,787 79,627
78,788 79,628

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 27 June 2025 and were signed by:





G P Bissell - Director


MEDICOTHERAPY SERVICES LIMITED (REGISTERED NUMBER: 07900359)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


1. STATUTORY INFORMATION

MEDICOTHERAPY SERVICES LIMITED is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 07900359

Registered office: C/o DPC Accountants
Stone House
55 Stone Road Business Park
Stoke on Trent
Staffordshire
ST4 6SR

2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY
(a) Critical accounting estimates and assumptions

The company makes estimates and assumptions concerning the future. The resulting accounting estimates will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are addressed below.

(i) Impairment of debtors

The company makes an estimate of the recoverable value of trade and other debtors. When assessing impairment of trade and other debtors, management considers factors including the current credit rating of the debtor, the ageing profile of debtors and historical experience. See debtors note for the net carrying amount of the debtors.

REVENUE RECOGNITION
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

FINANCIAL INSTRUMENTS
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.

For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics.


MEDICOTHERAPY SERVICES LIMITED (REGISTERED NUMBER: 07900359)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


2. ACCOUNTING POLICIES - continued
TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Amounts owed by group undertakings 82,194 83,141
Other debtors 1 1
82,195 83,142

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Trade creditors 1,440 1,965
VAT 1,141 1,045
Accruals and deferred income 1,625 1,451
4,206 4,461

6. RELATED PARTY DISCLOSURES

Transactions with directors are under normal market conditions and/or not material.

7. POST BALANCE SHEET EVENTS

There were no material events up to the date of approval of the financial statements by the board.